Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVIR | URGN | ARTV | ||
| Company | Atea Pharmaceuticals Inc | Urogen Pharma Ltd | Artiva Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.17 | 11.53 | 11.26 | ||
| High | 3.26 | 11.82 | 11.52 | ||
| Low | 3.16 | 11.31 | 10.78 | ||
| Last | 3.25 | 11.55 | 10.88 | ||
| Change | +0.09 | +0.10 | -0.09 | ||
| % Change | +2.85% | +0.87% | -0.78% | ||
| Volume | 146,022 | 452,489 | 25,181 | ||
| 20-Day Average Volume | 178,231 | 469,429 | 52,914 | ||
| Previous Close | 3.16 | 11.45 | 10.96 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.32 | 12.01 | 11.49 | ||
| 20-Day Raw Stochastic | 29.52% | 33.82% | 20.57% | ||
| 20-Day Relative Strength | 44.41% | 42.94% | 45.77% | ||
| Weighted Alpha | +0.94 | -34.27 | N/A | ||
| Today's Opinion | 100% Sell | 100% Sell | N/A | ||
| Previous Opinion | 100% Sell | 100% Sell | N/A | ||
| Last Month's Opinion | 72% Sell | 100% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.81% since 11/14/24 | -2.61% since 11/14/24 | +3.47% since 11/14/24 | ||
| Low | 3.10 on 11/20/24 | 10.62 on 11/18/24 | 10.00 on 11/18/24 | ||
| High | 3.35 on 11/15/24 | 11.95 on 11/15/24 | 11.57 on 11/20/24 | ||
| 1-Month | |||||
| %Chg | -9.47% since 10/21/24 | -7.75% since 10/21/24 | +3.77% since 10/21/24 | ||
| Low | 3.10 on 11/20/24 | 10.62 on 11/18/24 | 9.68 on 10/31/24 | ||
| High | 3.62 on 11/06/24 | 13.37 on 11/06/24 | 15.49 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | -14.92% since 08/21/24 | -22.33% since 08/21/24 | +7.99% since 08/21/24 | ||
| Low | 3.10 on 11/20/24 | 10.62 on 11/18/24 | 9.68 on 10/31/24 | ||
| High | 4.14 on 09/17/24 | 15.89 on 08/22/24 | 17.31 on 10/01/24 | ||
| 6-Month | |||||
| %Chg | -9.97% since 05/21/24 | -12.96% since 05/21/24 | N/A since 07/19/24 | ||
| Low | 3.10 on 11/20/24 | 10.62 on 11/18/24 | 9.68 on 10/31/24 | ||
| High | 4.14 on 09/17/24 | 20.70 on 06/14/24 | 17.31 on 10/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 266,903 | 268,548 | 266,207 | ||
| Shares Outstanding, K | 84,463 | 23,454 | 24,289 | ||
| Annual Sales | 0 | 82,710,000 | 33,492,000 | ||
| Annual Net Income | -135,960,000 | -102,240,000 | -27,696,000 | ||
| Last Quarter Sales | 0 | 25,200,000 | 0 | ||
| Last Quarter Net Income | -31,150,000 | -23,670,000 | -17,840,000 | ||
| 60-Month Beta | 0.17 | 1.12 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | -0.55 on 11/06/24 | -0.92 on 11/12/24 | ||
| Latest Earnings Date | 11/07/24 | 11/06/24 | 12/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||